兰索拉唑
对乙酰氨基酚
医学
生物利用度
药代动力学
交叉研究
药理学
加药
口服
止痛药
药物相互作用
奥美拉唑
安慰剂
病理
替代医学
作者
Masaki Sanaka,Yasushi Kuyama,Satoru Mineshita,Jinfeng Qi,Yoshinori Hanada,Iiku Enatsu,Hideyo Tanaka,Hideaki Makino,Masami Yamanaka
标识
DOI:10.1097/00004836-199907000-00014
摘要
Because of its minimal gastric toxicity, acetaminophen is the analgesic of choice for patients with gastric acid-related disorders. Because proton pump inhibitors are widely used, concomitant prescription of acetaminophen and lansoprazole would be prevalent. This crossover study was conducted to investigate an acetaminophen-lansoprazole interaction. On one occasion, each of six healthy, fasted, male volunteers ingested 1.0 g acetaminophen dissolved in 200 mL water. On another occasion, at least 1 week apart, 30 mg lansoprazole was administered orally, simultaneously with acetaminophen, after pretreatment with the same dose of lansoprazole once daily for 2 days. Plasma acetaminophen concentrations were measured at 0, 0.25, 0.5, 0.75, 1, 2, 3, 5, and 8 hours after dosing. The peak plasma concentration of acetaminophen and the time to its occurrence were significantly higher and shorter, respectively, during the lansoprazole session than during the control session. Neither the elimination half-life nor the area under the curve was significantly different between the two sessions. Lansoprazole hastens the absorption of acetaminophen solution, but little modifies its elimination rate and bioavailability.
科研通智能强力驱动
Strongly Powered by AbleSci AI